1.4 Early detection
There is currently no established benefit to early detection of MGUS, the pre-malignant phase of MM.
There is no indication for screening for MM in the general population. But patients with MGUS or smouldering myeloma require regular monitoring to assess for possible progression to MM.
There is no national screening program for non-hereditary NETs.